FDA inspection

Haupt Pharma Wuelfing GmbH: FDA inspection ending Mar 17, 2017

FDA inspection 1009773 · No Action Indicated (NAI) · Gronau (Leine)

Key facts

Inspection ID 1009773
Firm Haupt Pharma Wuelfing GmbH
FEI number 3003183252
Address Bethelner Landstr. 18
City Gronau (Leine)
Country Germany
Fiscal year 2017
Inspection end date Mar 17, 2017
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • Yes Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections